Radiation therapy of malignant melanomas: An evaluation of clinically used fractionation schemes
- 15 March 1981
- Vol. 47 (6), 1262-1266
- https://doi.org/10.1002/1097-0142(19810315)47:6<1262::aid-cncr2820470606>3.0.co;2-h
Abstract
To assess the importance of radiation dose fraction size in the treatment of malignant melanomas, the records of 48 patients (83 sites) treated at Tufts‐New England Medical Center from 1971 to 1979 have been retrospectively reviewed. During this period, the dose fractionation schemes evolved from standard fraction size to large‐dose techniques. Radiation fraction size was observed to be the major factor in the clinical response of melanoma. Fractions of 600–800 rad resulted in the best overall response (80%). The rapid fractionation scheme of 800–400–400 rad on successive days resulted in intermediate response (58%) and may be useful for the palliative treatment of selected patients.Keywords
This publication has 10 references indexed in Scilit:
- The relationship between total dose, number of fractions and fraction size in the response of malignant melanoma in patientsThe British Journal of Radiology, 1978
- Value of computed tomography in radiotherapy of lung cancerAmerican Journal of Roentgenology, 1978
- Combination chemotherapy in metastatic malignant melanoma.A randomized study of three DTIC-containing combinationsCancer, 1978
- Intralymphatic administration of BCG in melanoma patientsCancer Immunology, Immunotherapy, 1977
- Radiation therapy of malignant melanoma.Experience with high individual treatment dosesCancer, 1976
- Malignant melanoma. Role of node dissection reappraisedCancer, 1976
- Combination chemotherapy for disseminated malignant melanomaCancer, 1975
- The radiosensitivity of melanoma cells in cultureThe British Journal of Radiology, 1971
- RADIATION THERAPY OF PRIMARY AND METASTATIC MELANOMAAnnals of the New York Academy of Sciences, 1963